UNSPSC 51202417: Golimumab

A tumor necrosis factor (TNF) blocker indicated for the treatment of adult patients.

UNSPSC 51202417 Golimumab, a Commodity code, shows a significant mismatch between its nominal scope — a specific biologic immunosuppressant for rheumatoid arthritis and inflammatory bowel disease — and the recent state and local procurement activity tagged under it. The four most recent opportunities solicited under this code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for fire rescue (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations represent golimumab procurement or specialty biologic acquisitions. The issuing bodies span county health departments, state HHS commissions, municipal fire departments, and multi-state cooperative purchasing organizations, reflecting a broad jurisdictional mix rather than a concentrated buyer base for the code's actual pharmaceutical scope.

Recent activity under this code appears concentrated in the South and Upper Midwest. Seminole County, Florida posted an IFB for naloxone and drug deactivation systems due July 26, 2023 (note: the due-date stamp appears erroneous relative to the posted date of June 30, 2026). The City of Tampa, Florida issued an ITB for medical and first aid supplies with an estimated contract value of $700,000.00, designated as a sheltered-market opportunity for certified Small Local Business Enterprises and due March 13, 2026. Texas HHS issued an RFI on direct-to-manufacturer prescriptions with a response deadline of April 3, 2026, designed to gather vendor capabilities before a formal RFP. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, with contracts effective July 1, 2026 and administered through three authorized wholesalers. The code's nominal scope does not align with solicitation activity, suggesting either a tagging error in the procurement database or misclassification of opportunities at contract posting.